bioAffinity Technologies, Inc. (BIAFW) stock
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
bioAffinity Technologies gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
bioAffinity Technologies's gross profit for the twelve months ending Sep 30, 2023 was $245.29K. For fiscal 2022 it was $4.34K.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.34K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | $223.78K | +22188.8% |
| Q2 FY2023 | Jun 30, 2023 | $18.50K | +1495.2% |
| Q1 FY2023 | Mar 31, 2023 | $834 | – |
| Q4 FY2022 | Dec 31, 2022 | $2.17K | – |
| Q3 FY2022 | Sep 30, 2022 | $1.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $1.16K | – |